{"id":76523,"date":"2025-12-31T16:42:19","date_gmt":"2025-12-31T07:42:19","guid":{"rendered":"https:\/\/www.marketresearch.co.jp\/insights\/global-therapeutic-vaccines-market-industry-mordor\/"},"modified":"2026-09-15T08:25:00","modified_gmt":"2026-09-14T23:25:00","slug":"global-therapeutic-vaccines-market-industry-mordor","status":"publish","type":"post","link":"https:\/\/www.marketresearch.co.jp\/insights\/global-therapeutic-vaccines-market-industry-mordor\/","title":{"rendered":"\u6cbb\u7642\u7528\u30ef\u30af\u30c1\u30f3\u5e02\u5834\u898f\u6a21\u30fb\u30b7\u30a7\u30a2\u5206\u6790\uff1a\u6210\u9577\u52d5\u5411\u3068\u4e88\u6e2c (2025-2030\u5e74)"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/www.marketresearch.co.jp\/insights\/wp-content\/uploads\/2025\/12\/global-therapeutic-vaccines-market-industry_1663336164721_Therapeutic_vaccines_market_players.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.marketresearch.co.jp\/insights\/wp-content\/uploads\/2025\/12\/global-therapeutic-vaccines-market-industry-size-image-1751286625987.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-0\">\n    1. \u306f\u3058\u3081\u306b<\/p>\n<ul>\n<li class=\"toc-level-2\">\n          1.1 \u8abf\u67fb\u306e\u524d\u63d0\u3068\u5e02\u5834\u306e\u5b9a\u7fa9<\/p>\n<\/li>\n<li class=\"toc-level-2\">\n          1.2 \u8abf\u67fb\u7bc4\u56f2<\/p>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-1\">\n    2. \u8abf\u67fb\u65b9\u6cd5<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-2\">\n    3. \u30a8\u30b0\u30bc\u30af\u30c6\u30a3\u30d6\u30b5\u30de\u30ea\u30fc<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-3\">\n    4. \u5e02\u5834\u6982\u6cc1<\/p>\n<ul>\n<li class=\"toc-level-2\">\n          4.1 \u5e02\u5834\u6982\u8981<\/p>\n<\/li>\n<li class=\"toc-level-2\">\n          4.2 \u5e02\u5834\u306e\u63a8\u9032\u8981\u56e0<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          4.2.1 \u6162\u6027\u75be\u60a3\u304a\u3088\u3073\u611f\u67d3\u75c7\u306e\u6709\u75c5\u7387\u306e\u5897\u52a0<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.2.2 \u30ef\u30af\u30c1\u30f3\u7814\u7a76\u958b\u767a\u3078\u306e\u653f\u5e9c\u8cc7\u91d1\u306e\u5f37\u5316<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.2.3 \u816b\u760d\u30ef\u30af\u30c1\u30f3\u30d1\u30a4\u30d7\u30e9\u30a4\u30f3\u306b\u304a\u3051\u308b\u88fd\u85ac\/\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u306e\u6025\u5897<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.2.4 \u753b\u671f\u7684\u306amRNA\u30d9\u30fc\u30b9\u6cbb\u7642\u7528\u30ef\u30af\u30c1\u30f3\u306e\u627f\u8a8d<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.2.5 AI\u99c6\u52d5\u578b\u30cd\u30aa\u6297\u539f\u767a\u898b\u306b\u3088\u308b\u500b\u5225\u5316\u306e\u52a0\u901f<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.2.6 \u30aa\u30f3\u30b5\u30a4\u30c8\u30e2\u30b8\u30e5\u30e9\u30fc\u30de\u30a4\u30af\u30ed\u30d5\u30a1\u30af\u30c8\u30ea\u30fc\u88fd\u9020\u30e2\u30c7\u30eb<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">\n          4.3 \u5e02\u5834\u306e\u963b\u5bb3\u8981\u56e0<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          4.3.1 \u8cc7\u672c\u96c6\u7d04\u7684\u3067\u9ad8\u30ea\u30b9\u30af\u306a\u81e8\u5e8a\u958b\u767a\u30b5\u30a4\u30af\u30eb<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.3.2 \u53b3\u683c\u306a\u8907\u6570\u7ba1\u8f44\u533a\u57df\u306b\u308f\u305f\u308b\u898f\u5236\u4e0a\u306e\u30cf\u30fc\u30c9\u30eb<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.3.3 GMP\u30a6\u30a4\u30eb\u30b9\u30d9\u30af\u30bf\u30fc\/\u30d7\u30e9\u30b9\u30df\u30c9\u88fd\u9020\u80fd\u529b\u306e\u4e0d\u8db3<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.3.4 \u5f8c\u671fI-O\u8a66\u9a13\u306e\u5931\u6557\u306b\u3088\u308b\u6295\u8cc7\u5bb6\u5fc3\u7406\u306e\u6e1b\u9000<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">\n          4.4 \u898f\u5236\u74b0\u5883<\/p>\n<\/li>\n<li class=\"toc-level-2\">\n          4.5 \u30dd\u30fc\u30bf\u30fc\u306e5\u3064\u306e\u529b\u5206\u6790<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          4.5.1 \u65b0\u898f\u53c2\u5165\u306e\u8105\u5a01<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.5.2 \u8cb7\u3044\u624b\u306e\u4ea4\u6e09\u529b<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.5.3 \u4f9b\u7d66\u8005\u306e\u4ea4\u6e09\u529b<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.5.4 \u4ee3\u66ff\u54c1\u306e\u8105\u5a01<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          4.5.5 \u7af6\u4e89\u306e\u6fc0\u3057\u3055<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-4\">\n    5. \u5e02\u5834\u898f\u6a21\u3068\u6210\u9577\u4e88\u6e2c\uff08\u91d1\u984d\u3001\u7c73\u30c9\u30eb\uff09<\/p>\n<ul>\n<li class=\"toc-level-2\">\n          5.1 \u88fd\u54c1\u5225<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          5.1.1 \u81ea\u5df1\u514d\u75ab\u75be\u60a3\u30ef\u30af\u30c1\u30f3<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.1.2 \u795e\u7d4c\u75be\u60a3\u30ef\u30af\u30c1\u30f3<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.1.3 \u304c\u3093\u30ef\u30af\u30c1\u30f3<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.1.4 \u611f\u67d3\u75c7\u30ef\u30af\u30c1\u30f3<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.1.5 \u305d\u306e\u4ed6\u306e\u88fd\u54c1<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">\n          5.2 \u6280\u8853\u5225<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          5.2.1 \u540c\u7a2e\u30ef\u30af\u30c1\u30f3<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.2.2 \u81ea\u5df1\u30ef\u30af\u30c1\u30f3<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">\n          5.3 \u5e74\u9f62\u5c64\u5225<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          5.3.1 \u6210\u4eba<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.3.2 \u5c0f\u5150<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.3.3 \u9ad8\u9f62\u8005<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">\n          5.4 \u6d41\u901a\u30c1\u30e3\u30cd\u30eb\u5225<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          5.4.1 \u516c\u5171<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.4.2 \u6c11\u9593<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">\n          5.5 \u5730\u57df\u5225<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          5.5.1 \u5317\u7c73<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.1.1 \u7c73\u56fd<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.1.2 \u30ab\u30ca\u30c0<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.1.3 \u30e1\u30ad\u30b7\u30b3<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.5.2 \u30e8\u30fc\u30ed\u30c3\u30d1<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.2.1 \u30c9\u30a4\u30c4<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.2.2 \u30a4\u30ae\u30ea\u30b9<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.2.3 \u30d5\u30e9\u30f3\u30b9<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.2.4 \u30a4\u30bf\u30ea\u30a2<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.2.5 \u30b9\u30da\u30a4\u30f3<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.2.6 \u305d\u306e\u4ed6\u306e\u30e8\u30fc\u30ed\u30c3\u30d1<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.5.3 \u30a2\u30b8\u30a2\u592a\u5e73\u6d0b<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.3.1 \u4e2d\u56fd<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.3.2 \u65e5\u672c<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.3.3 \u30a4\u30f3\u30c9<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.3.4 \u30aa\u30fc\u30b9\u30c8\u30e9\u30ea\u30a2<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.3.5 \u97d3\u56fd<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.3.6 \u305d\u306e\u4ed6\u306e\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.5.4 \u4e2d\u6771\u304a\u3088\u3073\u30a2\u30d5\u30ea\u30ab<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.4.1 GCC<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.4.2 \u5357\u30a2\u30d5\u30ea\u30ab<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.4.3 \u305d\u306e\u4ed6\u306e\u4e2d\u6771\u304a\u3088\u3073\u30a2\u30d5\u30ea\u30ab<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          5.5.5 \u5357\u7c73<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.5.1 \u30d6\u30e9\u30b8\u30eb<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.5.2 \u30a2\u30eb\u30bc\u30f3\u30c1\u30f3<\/p>\n<\/li>\n<li class=\"toc-level-4\">\n          5.5.5.3 \u305d\u306e\u4ed6\u306e\u5357\u7c73<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-5\">\n    6. \u7af6\u5408\u60c5\u52e2<\/p>\n<ul>\n<li class=\"toc-level-2\">\n          6.1 \u5e02\u5834\u96c6\u4e2d\u5ea6<\/p>\n<\/li>\n<li class=\"toc-level-2\">\n          6.2 \u5e02\u5834\u30b7\u30a7\u30a2\u5206\u6790<\/p>\n<\/li>\n<li class=\"toc-level-2\">\n          6.3 \u4f01\u696d\u30d7\u30ed\u30d5\u30a1\u30a4\u30eb\uff08\u30b0\u30ed\u30fc\u30d0\u30eb\u6982\u8981\u3001\u5e02\u5834\u6982\u8981\u3001\u4e3b\u8981\u30bb\u30b0\u30e1\u30f3\u30c8\u3001\u5229\u7528\u53ef\u80fd\u306a\u8ca1\u52d9\u60c5\u5831\u3001\u6226\u7565\u60c5\u5831\u3001\u4e3b\u8981\u4f01\u696d\u306e\u5e02\u5834\u9806\u4f4d\/\u30b7\u30a7\u30a2\u3001\u88fd\u54c1&amp;\u30b5\u30fc\u30d3\u30b9\u3001\u304a\u3088\u3073\u6700\u8fd1\u306e\u52d5\u5411\u3092\u542b\u3080\uff09<\/p>\n<ul>\n<li class=\"toc-level-3\">\n          6.3.1 Agenus Inc.<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.2 Argos Therapeutics Inc.<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.3 Celldex Therapeutics Inc.<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.4 Dendreon Corp.<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.5 GlaxoSmithKline plc<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.6 Merck &amp; Co., Inc.<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.7 Novartis AG<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.8 Pfizer Inc.<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.9 Phio Pharmaceuticals Corp.<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.10 Inovio Pharmaceuticals<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.11 AstraZeneca plc<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.12 BioNTech SE<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.13 Moderna, Inc.<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.14 Sanofi SA<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.15 Bavarian Nordic A\/S<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.16 Gilead Sciences (Kite Pharma)<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.17 Takeda Pharmaceutical Co.<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.18 CSL Seqirus<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.19 CureVac N.V.<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.20 GeoVax Labs, Inc.<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.21 Vaccitech plc<\/p>\n<\/li>\n<li class=\"toc-level-3\">\n          6.3.22 Nykode Therapeutics<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-6\">\n    7. \u5e02\u5834\u6a5f\u4f1a&amp;\u5c06\u6765\u5c55\u671b<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u6cbb\u7642\u7528\u30ef\u30af\u30c1\u30f3\u5e02\u5834\u306e\u6982\u8981\u3092\u4ee5\u4e0b\u306b\u307e\u3068\u3081\u307e\u3057\u305f\u3002<\/p>\n<p># \u6cbb\u7642\u7528\u30ef\u30af\u30c1\u30f3\u5e02\u5834\u306e\u898f\u6a21\u3001\u30b7\u30a7\u30a2\u3001\u30c8\u30ec\u30f3\u30c9\u5206\u6790\uff082030\u5e74\u307e\u3067\uff09<\/p>\n<p>\u6cbb\u7642\u7528\u30ef\u30af\u30c1\u30f3\u5e02\u5834\u306f\u30012025\u5e74\u306b\u306f304.4\u5104\u7c73\u30c9\u30eb\u306b\u9054\u3057\u30012030\u5e74\u307e\u3067\u306b552.1\u5104\u7c73\u30c9\u30eb\u306b\u6210\u9577\u3059\u308b\u3068\u4e88\u6e2c\u3055\u308c\u3066\u304a\u308a\u3001\u4e88\u6e2c\u671f\u9593\u4e2d\u306e\u5e74\u5e73\u5747\u6210\u9577\u7387\uff08CAGR\uff09\u306f12.65%\u3067\u3059\u3002\u3053\u306e\u6210\u9577\u306f\u3001\u4e88\u9632\u63a5\u7a2e\u304b\u3089\u3001\u304c\u3093\u3084\u6162\u6027\u30a6\u30a4\u30eb\u30b9\u611f\u67d3\u75c7\u306a\u3069\u306e\u6d3b\u52d5\u6027\u75be\u60a3\u3092\u6cbb\u7642\u3059\u308b\u514d\u75ab\u7642\u6cd5\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3078\u306e\u8ee2\u63db\u306b\u3088\u3063\u3066\u63a8\u9032\u3055\u308c\u3066\u3044\u307e\u3059\u3002mRNA\u30ef\u30af\u30c1\u30f3\u306e\u753b\u671f\u7684\u306a\u627f\u8a8d\u3084AI\u3092\u6d3b\u7528\u3057\u305f\u30cd\u30aa\u30a2\u30f3\u30c1\u30b2\u30f3\u767a\u898b\u304c\u958b\u767a\u30b5\u30a4\u30af\u30eb\u3092\u77ed\u7e2e\u3057\u3001\u81e8\u5e8a\u7cbe\u5ea6\u3092\u5411\u4e0a\u3055\u305b\u3066\u3044\u307e\u3059\u3002\u30d1\u30f3\u30c7\u30df\u30c3\u30af\u4e2d\u306b\u5897\u5f37\u3055\u308c\u305f\u88fd\u9020\u80fd\u529b\u306f\u3001\u65b0\u305f\u306a\u30d1\u30a4\u30d7\u30e9\u30a4\u30f3\u306e\u8fc5\u901f\u306a\u30b9\u30b1\u30fc\u30eb\u30a2\u30c3\u30d7\u3092\u652f\u3048\u3001Project NextGen\u306e\u3088\u3046\u306a\u653f\u5e9c\u30d7\u30ed\u30b0\u30e9\u30e0\u306f\u521d\u671f\u6bb5\u968e\u306e\u30ea\u30b9\u30af\u3092\u8efd\u6e1b\u3059\u308b\u8cc7\u91d1\u3092\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002\u7814\u7a76\u958b\u767a\u3001\u81e8\u5e8a\u88fd\u9020\u3001\u30b3\u30fc\u30eb\u30c9\u30c1\u30a7\u30fc\u30f3\u6d41\u901a\u3092\u7d71\u5408\u3067\u304d\u308b\u4f01\u696d\u304c\u7af6\u4e89\u512a\u4f4d\u6027\u3092\u78ba\u7acb\u3057\u3001\u8907\u6570\u306e\u9069\u5fdc\u75c7\u306b\u5bfe\u5fdc\u3059\u308b\u30e2\u30b8\u30e5\u30fc\u30eb\u5f0f\u500b\u5225\u5316\u30ec\u30b8\u30e1\u30f3\u306e\u8fc5\u901f\u306a\u5c0e\u5165\u3092\u53ef\u80fd\u306b\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u4e3b\u8981\u306a\u5e02\u5834\u52d5\u5411\u306e\u8981\u70b9\uff1a<\/p>\n<p>*   \u88fd\u54c1\u30ab\u30c6\u30b4\u30ea\u30fc\u5225: 2024\u5e74\u306b\u306f\u304c\u3093\u30ef\u30af\u30c1\u30f3\u304c\u6cbb\u7642\u7528\u30ef\u30af\u30c1\u30f3\u5e02\u5834\u306e43.21%\u3092\u5360\u3081\u3001\u611f\u67d3\u75c7\u5019\u88dc\u306f2030\u5e74\u307e\u3067\u306b13.45%\u306eCAGR\u3067\u62e1\u5927\u3059\u308b\u3068\u4e88\u6e2c\u3055\u308c\u3066\u3044\u307e\u3059\u3002<br \/>\n*   \u6280\u8853\u5225: 2024\u5e74\u306b\u306f\u30a2\u30ed\u30b8\u30a7\u30cb\u30c3\u30af\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u304c65.34%\u306e\u53ce\u76ca\u30b7\u30a7\u30a2\u3092\u5360\u3081\u307e\u3057\u305f\u304c\u3001\u30aa\u30fc\u30c8\u30ed\u30ac\u30b9\u30a2\u30d7\u30ed\u30fc\u30c1\u306f2030\u5e74\u307e\u3067\u306b13.44%\u306eCAGR\u3067\u6700\u3082\u901f\u3044\u6210\u9577\u3092\u8a18\u9332\u3059\u308b\u3068\u898b\u8fbc\u307e\u308c\u3066\u3044\u307e\u3059\u3002<br \/>\n*   \u5e74\u9f62\u5c64\u5225: 2024\u5e74\u306b\u306f\u6210\u4eba\u60a3\u8005\u304c\u6cbb\u7642\u7528\u30ef\u30af\u30c1\u30f3\u5e02\u5834\u898f\u6a21\u306e62.45%\u3092\u5360\u3081\u3001\u5c0f\u5150\u7528\u9014\u306f2030\u5e74\u307e\u3067\u306b13.67%\u306eCAGR\u3067\u6210\u9577\u3057\u3066\u3044\u307e\u3059\u3002<br \/>\n*   \u6d41\u901a\u30c1\u30e3\u30cd\u30eb\u5225: 2024\u5e74\u306b\u306f\u516c\u5171\u30d7\u30ed\u30b0\u30e9\u30e0\u304c\u9700\u8981\u306e68.91%\u3092\u5360\u3081\u307e\u3057\u305f\u304c\u3001\u6c11\u9593\u65bd\u8a2d\u306f2030\u5e74\u307e\u3067\u306b13.34%\u306eCAGR\u3067\u6210\u9577\u3057\u3066\u3044\u307e\u3059\u3002<br \/>\n*   \u5730\u57df\u5225: 2024\u5e74\u306b\u306f\u5317\u7c73\u304c41.76%\u306e\u53ce\u76ca\u30ea\u30fc\u30c0\u30fc\u30b7\u30c3\u30d7\u3092\u7dad\u6301\u3057\u307e\u3057\u305f\u304c\u3001\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b\u5730\u57df\u306f2030\u5e74\u307e\u3067\u306b13.69%\u306eCAGR\u3067\u6700\u3082\u901f\u3044\u5730\u57df\u7684\u6210\u9577\u3092\u793a\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<p># \u4e16\u754c\u306e\u6cbb\u7642\u7528\u30ef\u30af\u30c1\u30f3\u5e02\u5834\u306e\u30c8\u30ec\u30f3\u30c9\u3068\u6d1e\u5bdf<\/p>\n<p>\u5e02\u5834\u3092\u727d\u5f15\u3059\u308b\u8981\u56e0\uff08\u30c9\u30e9\u30a4\u30d0\u30fc\uff09\uff1a<\/p>\n<p>*   \u6162\u6027\u30fb\u611f\u67d3\u75c7\u306e\u6709\u75c5\u7387\u4e0a\u6607: \u4e16\u754c\u7684\u306a\u9ad8\u9f62\u5316\u306f\u304c\u3093\u306e\u767a\u751f\u7387\u3092\u9ad8\u3081\u3001\u75c5\u539f\u4f53\u306e\u9032\u5316\u306f\u30a6\u30a4\u30eb\u30b9\u6027\u304a\u3088\u3073\u7d30\u83cc\u6027\u75be\u60a3\u306e\u8ca0\u62c5\u3092\u7dad\u6301\u3057\u3066\u3044\u307e\u3059\u3002\u6cbb\u7642\u7528\u30ef\u30af\u30c1\u30f3\u306f\u3001\u65e2\u5b58\u306e\u75be\u60a3\u3068\u95d8\u3046\u305f\u3081\u306b\u514d\u75ab\u30b7\u30b9\u30c6\u30e0\u3092\u8a13\u7df4\u3059\u308b\u3053\u3068\u3067\u3001\u3053\u308c\u3089\u306e\u6e80\u305f\u3055\u308c\u3066\u3044\u306a\u3044\u30cb\u30fc\u30ba\u306b\u5bfe\u5fdc\u3057\u307e\u3059\u3002\u304c\u3093\u3001\u6162\u6027B\u578b\u809d\u708e\u3001\u518d\u767a\u6027\u6027\u5668\u30d8\u30eb\u30da\u30b9\u306a\u3069\u304c\u4e3b\u8981\u306a\u30bf\u30fc\u30b2\u30c3\u30c8\u3067\u3042\u308a\u3001\u6301\u7d9a\u7684\u306a\u53cd\u5fdc\u306f\u751f\u6daf\u306b\u308f\u305f\u308b\u85ac\u7269\u7642\u6cd5\u3092\u8efd\u6e1b\u3057\u307e\u3059\u3002\u516c\u8846\u885b\u751f\u5f53\u5c40\u306f\u3001\u6cbb\u7642\u30ec\u30b8\u30e1\u30f3\u3092\u6162\u6027\u85ac\u306e\u8cbb\u7528\u5bfe\u52b9\u679c\u306e\u9ad8\u3044\u4ee3\u66ff\u624b\u6bb5\u3068\u898b\u306a\u3057\u3066\u304a\u308a\u3001\u6cbb\u7652\u306e\u53ef\u80fd\u6027\u3092\u8a55\u4fa1\u3059\u308b\u511f\u9084\u67a0\u7d44\u307f\u3092\u5968\u52b1\u3057\u3066\u3044\u307e\u3059\u3002<br \/>\n*   \u30ef\u30af\u30c1\u30f3R&#038;D\u3078\u306e\u653f\u5e9c\u8cc7\u91d1\u306e\u5f37\u5316: \u7c73\u56fd\u306fProject NextGen\u3092\u7acb\u3061\u4e0a\u3052\u3001\u4e88\u9632\u4ee5\u5916\u306e\u6cbb\u7642\u7528\u9014\u3092\u542b\u3080\u6b21\u4e16\u4ee3\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306b50\u5104\u7c73\u30c9\u30eb\u3092\u5272\u308a\u5f53\u3066\u307e\u3057\u305f\u3002BARDA\u306e\u6210\u679c\u9023\u52d5\u578b\u8cde\u306f\u3001\u30d1\u30f3\u30c7\u30df\u30c3\u30af\u5bfe\u5fdc\u3068\u6162\u6027\u75be\u60a3\u6cbb\u7642\u306e\u9593\u3067\u8ee2\u63db\u53ef\u80fd\u306a\u30c7\u30e5\u30a2\u30eb\u30e6\u30fc\u30b9\u6280\u8853\u3092\u512a\u5148\u3057\u3001GMP\u69cb\u7bc9\u3092\u52a0\u901f\u3057\u3001\u30b9\u30b1\u30fc\u30eb\u30a2\u30c3\u30d7\u306e\u30ea\u30b9\u30af\u3092\u8efd\u6e1b\u3057\u3066\u3044\u307e\u3059\u3002EU Horizon\u30d5\u30ec\u30fc\u30e0\u30ef\u30fc\u30af\u3067\u3082\u540c\u69d8\u306e\u53d6\u308a\u7d44\u307f\u304c\u898b\u3089\u308c\u3001CEPI\u306f\u591a\u56fd\u9593\u627f\u8a8d\u3092\u77ed\u7e2e\u3059\u308b\u30b0\u30ed\u30fc\u30d0\u30eb\u306a\u81e8\u5e8a\u8a66\u9a13\u306e\u6a19\u6e96\u5316\u3092\u8abf\u6574\u3057\u3066\u3044\u307e\u3059\u3002<br \/>\n*   \u30aa\u30f3\u30b3\u30ed\u30b8\u30fc\u30ef\u30af\u30c1\u30f3\u30d1\u30a4\u30d7\u30e9\u30a4\u30f3\u306b\u304a\u3051\u308b\u88fd\u85ac\/\u30d0\u30a4\u30aa\u30c6\u30c3\u30af\u306e\u6025\u5897: \u30c1\u30a7\u30c3\u30af\u30dd\u30a4\u30f3\u30c8\u963b\u5bb3\u5264\u306f\u514d\u75ab\u4ecb\u5728\u6027\u306e\u304c\u3093\u5236\u5fa1\u306e\u6982\u5ff5\u5b9f\u8a3c\u3092\u751f\u307f\u51fa\u3057\u3001\u6cbb\u7642\u7528\u30ef\u30af\u30c1\u30f3\u306f\u3053\u308c\u3089\u306e\u53cd\u5fdc\u3092\u5897\u5e45\u3057\u3066\u3044\u307e\u3059\u3002Moderna\u3068Merck\u306emRNA-4157\/Keytruda\u4f75\u7528\u7642\u6cd5\u306f\u30012025\u5e74\u306b\u30e1\u30e9\u30ce\u30fc\u30de\u306e\u7b2c3\u76f8\u8a66\u9a13\u306b\u9032\u307f\u3001\u80ba\u304c\u3093\u3084\u5927\u8178\u304c\u3093\u3078\u306e\u5fdc\u7528\u3092\u62e1\u5927\u3057\u3066\u3044\u307e\u3059\u3002\u5927\u624b\u88fd\u85ac\u4f1a\u793e\u3068\u306e\u63d0\u643a\u306f\u5f8c\u671f\u6bb5\u968e\u306e\u30ea\u30bd\u30fc\u30b9\u3092\u63d0\u4f9b\u3057\u3001\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u30d0\u30a4\u30aa\u30c6\u30c3\u30af\u4f01\u696d\u306f\u5171\u6709\u30e9\u30a4\u30d6\u30e9\u30ea\u304b\u3089\u8907\u6570\u306e\u5019\u88dc\u3092\u53cd\u5fa9\u958b\u767a\u3057\u3001\u8cc7\u7523\u3054\u3068\u306e\u30ea\u30b9\u30af\u3092\u4f4e\u6e1b\u3057\u3066\u3044\u307e\u3059\u3002<br \/>\n*   mRNA\u30d9\u30fc\u30b9\u6cbb\u7642\u7528\u30ef\u30af\u30c1\u30f3\u306e\u753b\u671f\u7684\u306a\u627f\u8a8d: 2025\u5e74\u306e\u6700\u521d\u306emRNA\u6cbb\u7642\u7528\u30ef\u30af\u30c1\u30f3\u306eFDA\u627f\u8a8d\u306f\u3001\u8102\u8cea\u30ca\u30ce\u7c92\u5b50\u9001\u9054\u3001\u514d\u75ab\u539f\u6027\u3001\u304a\u3088\u3073\u7ba1\u7406\u53ef\u80fd\u306a\u5b89\u5168\u6027\u30d7\u30ed\u30d5\u30a1\u30a4\u30eb\u3092\u691c\u8a3c\u3057\u307e\u3057\u305f\u3002\u30d1\u30f3\u30c7\u30df\u30c3\u30af\u6642\u4ee3\u306e\u65bd\u8a2d\u306f\u73fe\u5728\u3001\u30aa\u30f3\u30b3\u30ed\u30b8\u30fc\u304a\u3088\u3073\u6162\u6027\u611f\u67d3\u75c7\u88fd\u54c1\u306b\u79fb\u884c\u3057\u3066\u304a\u308a\u3001\u65b0\u898f\u30d0\u30a4\u30aa\u30ea\u30a2\u30af\u30bf\u30fc\u3068\u6bd4\u8f03\u3057\u3066\u5e02\u5834\u6295\u5165\u307e\u3067\u306e\u6642\u9593\u3092\u77ed\u7e2e\u3057\u3066\u3044\u307e\u3059\u3002mRNA\u306e\u30b3\u30fc\u30c7\u30a3\u30f3\u30b0\u306e\u67d4\u8edf\u6027\u306f\u8fc5\u901f\u306a\u500b\u5225\u5316\u3092\u30b5\u30dd\u30fc\u30c8\u3057\u3001\u7d44\u307f\u5408\u308f\u305b\u30ec\u30b8\u30e1\u30f3\u3092\u5bb9\u6613\u306b\u3057\u3001\u60a3\u8005\u56fa\u6709\u306e\u8ee2\u5e30\u3092\u6539\u5584\u3057\u3066\u3044\u307e\u3059\u3002<br \/>\n*   AI\u99c6\u52d5\u578b\u30cd\u30aa\u30a2\u30f3\u30c1\u30b2\u30f3\u767a\u898b\u306b\u3088\u308b\u500b\u5225\u5316\u306e\u52a0\u901f: AI\u30a2\u30eb\u30b4\u30ea\u30ba\u30e0\u306f\u3001\u60a3\u8005\u56fa\u6709\u306e\u816b\u760d\u5909\u7570\u304b\u3089\u30cd\u30aa\u30a2\u30f3\u30c1\u30b2\u30f3\u3092\u7279\u5b9a\u3059\u308b\u30d7\u30ed\u30bb\u30b9\u3092\u52a0\u901f\u3057\u3001\u500b\u5225\u5316\u3055\u308c\u305f\u6cbb\u7642\u7528\u30ef\u30af\u30c1\u30f3\u306e\u8a2d\u8a08\u3092\u53ef\u80fd\u306b\u3057\u3066\u3044\u307e\u3059\u3002<br \/>\n*   \u30aa\u30f3\u30b5\u30a4\u30c8\u30e2\u30b8\u30e5\u30fc\u30eb\u578b\u30de\u30a4\u30af\u30ed\u30d5\u30a1\u30af\u30c8\u30ea\u30fc\u88fd\u9020\u30e2\u30c7\u30eb: \u30e2\u30b8\u30e5\u30fc\u30eb\u578b\u30de\u30a4\u30af\u30ed\u30d5\u30a1\u30af\u30c8\u30ea\u30fc\u306f\u3001\u5206\u6563\u578b\u304b\u3064\u30aa\u30f3\u30c7\u30de\u30f3\u30c9\u306e\u88fd\u9020\u3092\u53ef\u80fd\u306b\u3057\u3001\u751f\u7523\u306e\u67d4\u8edf\u6027\u3068\u52b9\u7387\u3092\u9ad8\u3081\u307e\u3059\u3002<\/p>\n<p>\u5e02\u5834\u3092\u6291\u5236\u3059\u308b\u8981\u56e0\uff08\u30ea\u30b9\u30c8\u30ec\u30a4\u30f3\u30c4\uff09\uff1a<\/p>\n<p>*   \u8cc7\u672c\u96c6\u7d04\u7684\u3067\u9ad8\u30ea\u30b9\u30af\u306a\u81e8\u5e8a\u958b\u767a\u30b5\u30a4\u30af\u30eb: \u6cbb\u7642\u7528\u30ef\u30af\u30c1\u30f3\u306f\u3001\u91cd\u8981\u306a\u30c7\u30fc\u30bf\u304c\u5f97\u3089\u308c\u308b\u307e\u3067\u306b\u6570\u5e74\u3001\u6570\u767e\u4e07\u30c9\u30eb\u306e\u6295\u8cc7\u3092\u5fc5\u8981\u3068\u3057\u307e\u3059\u3002\u751f\u7269\u5b66\u7684\u88fd\u5264\u306e\u88fd\u9020\u306f\u627f\u8a8d\u524d\u306b1\u5104\u7c73\u30c9\u30eb\u3092\u8981\u3059\u308b\u3053\u3068\u3082\u3042\u308a\u3001\u521d\u671f\u6bb5\u968e\u306e\u4f01\u696d\u306e\u8ca1\u52d9\u3092\u5727\u8feb\u3057\u307e\u3059\u3002<br \/>\n*   \u53b3\u683c\u306a\u8907\u6570\u7ba1\u8f44\u306b\u308f\u305f\u308b\u898f\u5236\u4e0a\u306e\u30cf\u30fc\u30c9\u30eb: \u6cbb\u7642\u7528\u30ef\u30af\u30c1\u30f3\u306f\u3001\u751f\u7269\u5b66\u7684\u88fd\u5264\u3001\u7d30\u80de\u7642\u6cd5\u3001\u304a\u3088\u3073\u8907\u5408\u88fd\u54c1\u306e\u6cd5\u898f\u306e\u4ea4\u5dee\u70b9\u306b\u4f4d\u7f6e\u3057\u3066\u3044\u307e\u3059\u3002FDA\u306e\u30ac\u30a4\u30c0\u30f3\u30b9\u306f\u9032\u5316\u3092\u7d9a\u3051\u3066\u304a\u308a\u3001EMA\u306f\u7c73\u56fd\u306e\u8981\u4ef6\u3068\u306f\u7570\u306a\u308b\u72ec\u81ea\u306e\u5148\u9032\u6cbb\u7642\u898f\u5247\u3092\u7dad\u6301\u3057\u3066\u3044\u307e\u3059\u3002<br \/>\n*   GMP\u30a6\u30a4\u30eb\u30b9\u30d9\u30af\u30bf\u30fc\/\u30d7\u30e9\u30b9\u30df\u30c9\u5bb9\u91cf\u306e\u4e0d\u8db3: GMP\uff08Good Manufacturing Practice\uff09\u306b\u6e96\u62e0\u3057\u305f\u30a6\u30a4\u30eb\u30b9\u30d9\u30af\u30bf\u30fc\u3084\u30d7\u30e9\u30b9\u30df\u30c9\u306e\u88fd\u9020\u80fd\u529b\u306e\u4e0d\u8db3\u306f\u3001\u6cbb\u7642\u7528\u30ef\u30af\u30c1\u30f3\u306e\u958b\u767a\u3068\u751f\u7523\u3092\u5236\u7d04\u3059\u308b\u8981\u56e0\u3068\u306a\u3063\u3066\u3044\u307e\u3059\u3002<br \/>\n*   \u5f8c\u671f\u6bb5\u968e\u306eI-O\uff08\u514d\u75ab\u816b\u760d\u5b66\uff09\u8a66\u9a13\u306e\u5931\u6557\u306b\u3088\u308b\u30bb\u30f3\u30c1\u30e1\u30f3\u30c8\u306e\u4f4e\u4e0b: \u514d\u75ab\u816b\u760d\u5b66\u5206\u91ce\u306b\u304a\u3051\u308b\u5f8c\u671f\u81e8\u5e8a\u8a66\u9a13\u306e\u5931\u6557\u306f\u3001\u6295\u8cc7\u5bb6\u306e\u4fe1\u983c\u3092\u640d\u306a\u3044\u3001\u5e02\u5834\u5168\u4f53\u306e\u30bb\u30f3\u30c1\u30e1\u30f3\u30c8\u3092\u51b7\u3048\u8fbc\u307e\u305b\u308b\u53ef\u80fd\u6027\u304c\u3042\u308a\u307e\u3059\u3002<\/p>\n<p># \u30bb\u30b0\u30e1\u30f3\u30c8\u5206\u6790<\/p>\n<p>*   \u88fd\u54c1\u5225\uff1a\u304c\u3093\u30ef\u30af\u30c1\u30f3\u304c\u5e02\u5834\u5909\u9769\u3092\u4e3b\u5c0e<br \/>\n    \u304c\u3093\u30ef\u30af\u30c1\u30f3\u306f2025\u5e74\u306b132\u5104\u7c73\u30c9\u30eb\u306b\u9054\u3057\u3001\u6cbb\u7642\u7528\u30ef\u30af\u30c1\u30f3\u5e02\u5834\u898f\u6a21\u306e43.21%\u3092\u5360\u3081\u3001\u30aa\u30f3\u30b3\u30ed\u30b8\u30fc\u304c\u5546\u696d\u7684\u63a1\u7528\u306e\u8981\u3067\u3042\u308b\u3053\u3068\u3092\u793a\u3057\u3066\u3044\u307e\u3059\u3002\u30c1\u30a7\u30c3\u30af\u30dd\u30a4\u30f3\u30c8\u963b\u5bb3\u5264\u3068\u306e\u4f75\u7528\u30ec\u30b8\u30e1\u30f3\u306f\u53cd\u5fdc\u306e\u6301\u7d9a\u6027\u3092\u9ad8\u3081\u3001\u304c\u3093\u304c\u6cbb\u7642\u7528\u30ef\u30af\u30c1\u30f3\u5e02\u5834\u5168\u4f53\u306b\u8ca2\u732e\u3057\u3066\u3044\u307e\u3059\u3002\u611f\u67d3\u75c7\u6cbb\u7642\u85ac\u306f71\u5104\u7c73\u30c9\u30eb\u3068\u5c0f\u3055\u3044\u3082\u306e\u306e\u3001\u6162\u6027B\u578b\u809d\u708e\u3084\u30d8\u30eb\u30da\u30b9\u5019\u88dc\u306e\u9032\u5c55\u306b\u3088\u308a13.45%\u306eCAGR\u3067\u62e1\u5927\u3057\u3066\u3044\u307e\u3059\u3002\u81ea\u5df1\u514d\u75ab\u75be\u60a3\u304a\u3088\u3073\u795e\u7d4c\u75be\u60a3\u30ab\u30c6\u30b4\u30ea\u30fc\u306f\u307e\u3060\u521d\u671f\u6bb5\u968e\u3067\u3059\u304c\u3001\u30d1\u30a4\u30d7\u30e9\u30a4\u30f3\u306e\u591a\u69d8\u6027\u306b\u3068\u3063\u3066\u91cd\u8981\u3067\u3042\u308a\u3001\u5171\u6709\u88fd\u9020\u304a\u3088\u3073\u898f\u5236\u5b66\u7fd2\u66f2\u7dda\u3092\u6d3b\u7528\u3057\u305f\u3044\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u958b\u767a\u8005\u3092\u60f9\u304d\u3064\u3051\u3066\u3044\u307e\u3059\u3002\u591a\u767a\u6027\u786c\u5316\u75c7\u306a\u3069\u306e\u75be\u60a3\u3092\u6a19\u7684\u3068\u3059\u308b\u9006\u30ef\u30af\u30c1\u30f3\u3084\u8010\u6027\u8a98\u5c0e\u30ef\u30af\u30c1\u30f3\u306e\u958b\u767a\u306b\u30d9\u30f3\u30c1\u30e3\u30fc\u8cc7\u91d1\u304c\u518d\u914d\u5206\u3055\u308c\u3066\u304a\u308a\u3001\u795e\u7d4c\u75be\u60a3\u30d7\u30ed\u30b8\u30a7\u30af\u30c8\uff08\u30bf\u30a6\u304a\u3088\u3073\u30a2\u30eb\u30d5\u30a1\u30b7\u30cc\u30af\u30ec\u30a4\u30f3\u30ef\u30af\u30c1\u30f3\u3092\u542b\u3080\uff09\u306f\u4e2d\u671f\u6bb5\u968e\u306e\u8a66\u9a13\u306b\u9032\u3093\u3067\u3044\u307e\u3059\u3002<br \/>\n*   \u6280\u8853\u5225\uff1a\u30a2\u30ed\u30b8\u30a7\u30cb\u30c3\u30af\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u304c\u30aa\u30fc\u30c8\u30ed\u30ac\u30b9\u6210\u9577\u306b\u3082\u304b\u304b\u308f\u3089\u305a\u512a\u52e2<br \/>\n    \u30a2\u30ed\u30b8\u30a7\u30cb\u30c3\u30af\u88fd\u5264\u306f2025\u5e74\u306b199\u5104\u7c73\u30c9\u30eb\u3092\u751f\u6210\u3057\u3001\u6cbb\u7642\u7528\u30ef\u30af\u30c1\u30f3\u5e02\u5834\u898f\u6a21\u306e65.34%\u306b\u76f8\u5f53\u3057\u307e\u3059\u3002\u3053\u308c\u306f\u3001\u6d41\u901a\u3092\u7c21\u7d20\u5316\u3059\u308b\u6a19\u6e96\u5316\u3055\u308c\u305f\u65e2\u88fd\u30d5\u30a9\u30fc\u30de\u30c3\u30c8\u306b\u3088\u308b\u3082\u306e\u3067\u3059\u3002\u30aa\u30fc\u30c8\u30ed\u30ac\u30b9\u30a2\u30d7\u30ed\u30fc\u30c1\u306f\u3001\u30b7\u30fc\u30b1\u30f3\u30b7\u30f3\u30b0\u3068\u88fd\u9020\u81ea\u52d5\u5316\u304c\u30ea\u30fc\u30c9\u30bf\u30a4\u30e0\u3092\u77ed\u7e2e\u3059\u308b\u305f\u3081\u30012030\u5e74\u307e\u3067\u306b13.44%\u306eCAGR\u3092\u8a18\u9332\u3057\u3066\u3044\u307e\u3059\u3002\u60a3\u8005\u56fa\u6709\u306e\u30cd\u30aa\u30a2\u30f3\u30c1\u30b2\u30f3\u306f\u3001\u7279\u306b\u56fa\u5f62\u816b\u760d\u306b\u304a\u3044\u3066\u7cbe\u5ea6\u3092\u5411\u4e0a\u3055\u305b\u3001\u30d7\u30ec\u30df\u30a2\u30e0\u4fa1\u683c\u3092\u6b63\u5f53\u5316\u3059\u308b\u9ad8\u3044\u5ba2\u89b3\u7684\u594f\u52b9\u7387\u3092\u3082\u305f\u3089\u3057\u307e\u3059\u3002\u30cf\u30a4\u30d6\u30ea\u30c3\u30c9\u30a2\u30fc\u30ad\u30c6\u30af\u30c1\u30e3\uff08\u5171\u6709\u8102\u8cea\u30ca\u30ce\u7c92\u5b50\u30b3\u30a2\u3068\u500b\u5225\u5316\u3055\u308c\u305fmRNA\u30a4\u30f3\u30b5\u30fc\u30c8\u306e\u7d44\u307f\u5408\u308f\u305b\uff09\u304c\u767b\u5834\u3057\u3001\u30b9\u30b1\u30fc\u30e9\u30d3\u30ea\u30c6\u30a3\u3068\u500b\u5225\u5316\u306e\u30d0\u30e9\u30f3\u30b9\u3092\u53d6\u3063\u3066\u3044\u307e\u3059\u3002AI\u30a2\u30eb\u30b4\u30ea\u30ba\u30e0\u304c\u30a8\u30d4\u30c8\u30fc\u30d7\u9078\u629e\u3092\u3055\u3089\u306b\u6d17\u7df4\u3055\u305b\u308b\u306b\u3064\u308c\u3066\u3001\u30aa\u30fc\u30c8\u30ed\u30ac\u30b9\u304a\u3088\u3073\u300c\u30bb\u30df\u500b\u5225\u5316\u300d\u30d5\u30a9\u30fc\u30de\u30c3\u30c8\u304c\u6cbb\u7642\u7528\u30ef\u30af\u30c1\u30f3\u5e02\u5834\u306e\u30b7\u30a7\u30a2\u3092\u9ad8\u3081\u308b\u3068\u4e88\u60f3\u3055\u308c\u307e\u3059\u3002<br \/>\n*   \u5e74\u9f62\u5c64\u5225\uff1a\u6210\u4eba\u5411\u3051\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u304c\u73fe\u5728\u306e\u9700\u8981\u3092\u727d\u5f15<br \/>\n    \u304c\u3093\u306e\u6709\u75c5\u7387\u3068\u6162\u6027\u30a6\u30a4\u30eb\u30b9\u8ca0\u8377\u304c\u9ad8\u9f62\u8005\u5c64\u306b\u504f\u3063\u3066\u3044\u308b\u305f\u3081\u3001\u6210\u4eba\u304c2024\u5e74\u306e\u53ce\u76ca\u306e62.45%\u3092\u5360\u3081\u307e\u3057\u305f\u3002\u652f\u6255\u8005\u306e\u65b9\u91dd\u306f\u3001\u751f\u6daf\u306b\u308f\u305f\u308b\u6297\u30a6\u30a4\u30eb\u30b9\u307e\u305f\u306f\u514d\u75ab\u6291\u5236\u30ec\u30b8\u30e1\u30f3\u3092\u8efd\u6e1b\u3059\u308b\u6cbb\u7642\u7528\u30ef\u30af\u30c1\u30f3\u3092\u652f\u6301\u3057\u3001\u6210\u4eba\u3067\u306e\u63a1\u7528\u3092\u4fc3\u9032\u3057\u3066\u3044\u307e\u3059\u3002\u5c0f\u5150\u5411\u3051\u306f\u898f\u6a21\u304c\u5c0f\u3055\u3044\u3082\u306e\u306e\u3001\u898f\u5236\u4e0a\u306e\u30a4\u30f3\u30bb\u30f3\u30c6\u30a3\u30d6\u3001\u5e0c\u5c11\u75be\u60a3\u3078\u306e\u7126\u70b9\u3001\u5c0f\u5150\u795e\u7d4c\u81a0\u816b\u306a\u3069\u306e\u75be\u60a3\u306b\u5bfe\u3059\u308b\u514d\u75ab\u8abf\u7bc0\u6cbb\u7642\u3078\u306e\u89aa\u306e\u53d7\u5bb9\u306e\u9ad8\u307e\u308a\u306b\u652f\u3048\u3089\u308c\u300113.67%\u306eCAGR\u3067\u62e1\u5927\u3057\u3066\u3044\u307e\u3059\u3002\u88fd\u5264\u79d1\u5b66\u306f\u3001\u30a2\u30b8\u30e5\u30d0\u30f3\u30c8\u5f37\u5ea6\u3068\u6295\u4e0e\u983b\u5ea6\u3092\u767a\u9054\u4e2d\u306e\u514d\u75ab\u30b7\u30b9\u30c6\u30e0\u306b\u5408\u308f\u305b\u3066\u8abf\u6574\u3057\u3001\u6b74\u53f2\u7684\u306a\u5b89\u5168\u6027\u61f8\u5ff5\u3092\u514b\u670d\u3057\u3001\u6cbb\u7642\u7528\u30ef\u30af\u30c1\u30f3\u5e02\u5834\u3092\u62e1\u5927\u3057\u3066\u3044\u307e\u3059\u3002<br \/>\n*   \u6d41\u901a\u30c1\u30e3\u30cd\u30eb\u5225\uff1a\u516c\u5171\u90e8\u9580\u304c\u652f\u914d\u3092\u7dad\u6301<br \/>\n    \u653f\u5e9c\u306e\u533b\u7642\u30b5\u30fc\u30d3\u30b9\u3084\u591a\u56fd\u9593\u8abf\u9054\u6a5f\u95a2\u3092\u4e3b\u3068\u3059\u308b\u516c\u5171\u30d7\u30ed\u30b0\u30e9\u30e0\u306f\u3001\u96c6\u4e2d\u578b\u30b3\u30fc\u30eb\u30c9\u30c1\u30a7\u30fc\u30f3\u8cc7\u7523\u3068\u5927\u91cf\u8cfc\u5165\u529b\u3092\u6d3b\u7528\u3057\u30012024\u5e74\u306e\u6295\u4e0e\u91cf\u306e68.91%\u3092\u78ba\u4fdd\u3057\u307e\u3057\u305f\u3002\u5c02\u9580\u306e\u304c\u3093\u30af\u30ea\u30cb\u30c3\u30af\u3084\u500b\u5225\u5316\u533b\u7642\u30bb\u30f3\u30bf\u30fc\u3092\u542b\u3080\u6c11\u9593\u65bd\u8a2d\u306f\u3001\u30aa\u30fc\u30c8\u30ed\u30ac\u30b9\u304a\u3088\u3073\u4f75\u7528\u30ec\u30b8\u30e1\u30f3\u304c\u500b\u5225\u5316\u3055\u308c\u305f\u30ed\u30b8\u30b9\u30c6\u30a3\u30af\u30b9\u3092\u5fc5\u8981\u3068\u3059\u308b\u305f\u3081\u300113.34%\u306eCAGR\u3067\u6210\u9577\u3057\u3066\u3044\u307e\u3059\u3002\u5728\u5b85\u8f38\u6db2\u30aa\u30d7\u30b7\u30e7\u30f3\u3082\u691c\u8a0e\u3055\u308c\u3066\u304a\u308a\u3001\u6d41\u901a\u30e2\u30c7\u30eb\u306e\u5c06\u6765\u7684\u306a\u591a\u69d8\u5316\u3068\u6cbb\u7642\u7528\u30ef\u30af\u30c1\u30f3\u5e02\u5834\u306e\u6f38\u9032\u7684\u306a\u62e1\u5927\u3092\u793a\u5506\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<p># \u5730\u57df\u5206\u6790<\/p>\n<p>*   \u5317\u7c73: 2024\u5e74\u306b\u306f\u4e16\u754c\u306e\u53ce\u76ca\u306e41.76%\u3092\u5360\u3081\u307e\u3057\u305f\u3002FDA\u306e\u753b\u671f\u7684\u306a\u6307\u5b9a\u3001\u96c6\u4e2d\u3057\u305fVC\u8cc7\u91d1\u3001\u8fc5\u901f\u306a\u767b\u9332\u30cd\u30c3\u30c8\u30ef\u30fc\u30af\u304c\u5f37\u307f\u3067\u3059\u3002Project NextGen\u3084BARDA\u306e\u52a9\u6210\u91d1\u304c\u5b66\u8853\u30fb\u7523\u696d\u30cf\u30d6\u3092\u652f\u3048\u3001Merck\u3084Pfizer\u306e\u5de5\u5834\u62e1\u5f35\u304c\u4f9b\u7d66\u80fd\u529b\u3092\u5897\u5f37\u3057\u3066\u3044\u307e\u3059\u3002\u511f\u9084\u67a0\u7d44\u307f\u306f\u65e9\u671f\u63a1\u7528\u3092\u5968\u52b1\u3057\u3066\u3044\u307e\u3059\u3002<br \/>\n*   \u6b27\u5dde: \u91cd\u8981\u306a\u5b98\u6c11\u30b3\u30f3\u30bd\u30fc\u30b7\u30a2\u30e0\u3068Horizon Europe\u52a9\u6210\u91d1\u304c\u7ffb\u8a33\u7814\u7a76\u3092\u5c0e\u3044\u3066\u3044\u307e\u3059\u3002EMA\u306ePRIME\u304a\u3088\u3073\u6761\u4ef6\u4ed8\u304d\u627f\u8a8d\u30d7\u30ed\u30b0\u30e9\u30e0\u306f\u3001\u30c9\u30a4\u30c4\u3068\u30d5\u30e9\u30f3\u30b9\u306e\u4fa1\u5024\u30d9\u30fc\u30b9\u306e\u4fa1\u683c\u8a2d\u5b9a\u30d1\u30a4\u30ed\u30c3\u30c8\u3068\u9023\u643a\u3057\u3001\u9ad8\u30cb\u30fc\u30ba\u9069\u5fdc\u75c7\u306e\u65e9\u671f\u5e02\u5834\u53c2\u5165\u3092\u53ef\u80fd\u306b\u3057\u3066\u3044\u307e\u3059\u3002WACKER\u306emRNA\u30bb\u30f3\u30bf\u30fc\u306e\u3088\u3046\u306a\u65bd\u8a2d\u304c\u5927\u9678\u306e\u4f9b\u7d66\u30bb\u30ad\u30e5\u30ea\u30c6\u30a3\u3092\u5f37\u5316\u3057\u3066\u3044\u307e\u3059\u3002\u3057\u304b\u3057\u3001\u65ad\u7247\u5316\u3055\u308c\u305f\u56fd\u5bb6\u652f\u6255\u8005\u4ea4\u6e09\u304c\u5747\u4e00\u306a\u30a2\u30af\u30bb\u30b9\u3092\u9045\u3089\u305b\u308b\u53ef\u80fd\u6027\u304c\u3042\u308a\u307e\u3059\u3002<br \/>\n*   \u30a2\u30b8\u30a2\u592a\u5e73\u6d0b: 2030\u5e74\u307e\u3067\u306b13.69%\u306eCAGR\u3067\u6700\u3082\u901f\u3044\u6210\u9577\u3092\u9042\u3052\u3066\u3044\u307e\u3059\u3002\u4e2d\u56fd\u306e\u898f\u5236\u8fd1\u4ee3\u5316\u3068\u88fd\u9020\u30b3\u30b9\u30c8\u512a\u4f4d\u6027\u304c\u727d\u5f15\u3057\u3066\u3044\u307e\u3059\u3002\u73fe\u5730\u306e\u30d0\u30a4\u30aa\u30c6\u30c3\u30af\u4f01\u696d\u306f\u3001\u7279\u8a31\u9023\u643a\u3092\u6d3b\u7528\u3057\u3066\u6b27\u7c73\u4f01\u696d\u3068\u5171\u540c\u958b\u767a\u3057\u3001\u30b7\u30f3\u30ac\u30dd\u30fc\u30eb\u3084\u97d3\u56fd\u306e\u65b0\u3057\u3044CDMO\u30ad\u30e3\u30f3\u30d1\u30b9\u304c\u30b0\u30ed\u30fc\u30d0\u30eb\u30af\u30e9\u30a4\u30a2\u30f3\u30c8\u306b\u4f9b\u7d66\u3057\u3066\u3044\u307e\u3059\u3002\u65e5\u672c\u306e\u9ad8\u9f62\u5316\u3068\u30aa\u30f3\u30b3\u30ed\u30b8\u30fc\u30b1\u30a2\u3078\u306e\u30d7\u30ec\u30df\u30a2\u30e0\u511f\u9084\u306f\u5358\u4fa1\u3092\u62bc\u3057\u4e0a\u3052\u3001\u5730\u57df\u653f\u5e9c\u3082\u30b3\u30fc\u30eb\u30c9\u30c1\u30a7\u30fc\u30f3\u306e\u30a2\u30c3\u30d7\u30b0\u30ec\u30fc\u30c9\u306b\u8cc7\u91d1\u3092\u63d0\u4f9b\u3057\u3001\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b\u5730\u57df\u306e\u6cbb\u7642\u7528\u30ef\u30af\u30c1\u30f3\u5e02\u5834\u306b\u304a\u3051\u308b\u5f71\u97ff\u529b\u3092\u5f37\u5316\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<p># \u7af6\u4e89\u74b0\u5883<\/p>\n<p>\u6cbb\u7642\u7528\u30ef\u30af\u30c1\u30f3\u5e02\u5834\u306f\u4e2d\u7a0b\u5ea6\u306b\u7d30\u5206\u5316\u3055\u308c\u3066\u304a\u308a\u3001\u4e0a\u4f4d5\u793e\u304c2024\u5e74\u306e\u53ce\u76ca\u306e\u7d0445%\u3092\u652f\u914d\u3057\u3066\u3044\u307e\u3059\u3002Merck\u3001GSK\u3001Pfizer\u306a\u3069\u306e\u5927\u624b\u88fd\u85ac\u4f1a\u793e\u306f\u3001\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u30d0\u30a4\u30aa\u30c6\u30c3\u30af\u4f01\u696d\u3068mRNA\u304a\u3088\u3073\u30a6\u30a4\u30eb\u30b9\u30d9\u30af\u30bf\u30fc\u30d1\u30a4\u30d7\u30e9\u30a4\u30f3\u3092\u5171\u540c\u958b\u767a\u3057\u3066\u3044\u307e\u3059\u3002\u4f01\u696d\u306f\u8102\u8cea\u30ca\u30ce\u7c92\u5b50IP\u306e\u78ba\u4fdd\u3001\u30d7\u30e9\u30b9\u30df\u30c9\u4f9b\u7d66\u306e\u78ba\u4fdd\u3001\u5c02\u9580\u306eCDMO\u306e\u8cb7\u53ce\u3092\u901a\u3058\u3066\u5782\u76f4\u7d71\u5408\u3092\u5f37\u5316\u3057\u3066\u3044\u307e\u3059\u3002\u30d0\u30a4\u30aa\u30c6\u30c3\u30af\u5c02\u9580\u4f01\u696d\u306f\u3001\u72ec\u81ea\u306e\u6297\u539f\u9078\u629e\u30a2\u30eb\u30b4\u30ea\u30ba\u30e0\u3084\u96fb\u6c17\u7a7f\u5b54\u30d1\u30c3\u30c1\u306a\u3069\u306e\u30c7\u30d0\u30a4\u30b9\u652f\u63f4\u9001\u9054\u3092\u901a\u3058\u3066\u5dee\u5225\u5316\u3092\u56f3\u3063\u3066\u3044\u307e\u3059\u3002AI\u30cd\u30a4\u30c6\u30a3\u30d6\u4f01\u696d\u306f\u3001\u8a3a\u65ad\u4f01\u696d\u3068\u65e9\u671f\u306b\u63d0\u643a\u3057\u3001\u30ef\u30af\u30c1\u30f3\u3092\u816b\u760d\u5909\u7570\u8ca0\u8377\u306b\u5408\u308f\u305b\u3001\u5305\u62ec\u7684\u306a\u6cbb\u7642\u30a8\u30b3\u30b7\u30b9\u30c6\u30e0\u3092\u69cb\u7bc9\u3057\u3066\u3044\u307e\u3059\u3002\u4fa1\u683c\u8a2d\u5b9a\u529b\u306f\u9069\u5fdc\u75c7\u306b\u3088\u3063\u3066\u7570\u306a\u308a\u3001\u30aa\u30f3\u30b3\u30ed\u30b8\u30fc\u306f\u30d7\u30ec\u30df\u30a2\u30e0\u511f\u9084\u3092\u3001\u611f\u67d3\u75c7\u6cbb\u7642\u85ac\u306f\u91cf\u3092\u91cd\u8996\u3057\u307e\u3059\u3002\u4f01\u696d\u306f\u30dd\u30fc\u30c8\u30d5\u30a9\u30ea\u30aa\u306e\u30d0\u30e9\u30f3\u30b9\u3092\u53d6\u308a\u3001\u30ad\u30e3\u30c3\u30b7\u30e5\u30d5\u30ed\u30fc\u306e\u5b89\u5b9a\u6027\u3092\u7dad\u6301\u3057\u306a\u304c\u3089\u3001\u9ad8\u30ea\u30b9\u30af\u30fb\u9ad8\u30ea\u30bf\u30fc\u30f3\u306e\u500b\u5225\u5316\u30d7\u30ed\u30b0\u30e9\u30e0\u3092\u8ffd\u6c42\u3057\u3066\u3044\u307e\u3059\u3002\u8cb7\u53ce\u30fb\u5408\u4f75\uff08M&#038;A\uff09\u306f\u3001\u65e2\u5b58\u4f01\u696d\u304c\u6280\u8853\u30ae\u30e3\u30c3\u30d7\u3092\u57cb\u3081\u3001\u88fd\u9020\u62e0\u70b9\u3092\u7d71\u5408\u3059\u308b\u306b\u3064\u308c\u3066\u7d99\u7d9a\u3059\u308b\u3068\u4e88\u60f3\u3055\u308c\u30012030\u5e74\u307e\u3067\u306b\u6cbb\u7642\u7528\u30ef\u30af\u30c1\u30f3\u5e02\u5834\u306e\u96c6\u4e2d\u5ea6\u304c\u9ad8\u307e\u308b\u3067\u3057\u3087\u3046\u3002<\/p>\n<p>\u4e3b\u8981\u4f01\u696d:<\/p>\n<p>*   Phio Pharmaceuticals Corp.<br \/>\n*   GSK plc.<br \/>\n*   Merck &#038; Co., Inc.<br \/>\n*   Pfizer Inc.<br \/>\n*   Agenus Inc.<\/p>\n<p># \u6700\u8fd1\u306e\u696d\u754c\u52d5\u5411<\/p>\n<p>*   2025\u5e744\u6708: \u82f1\u56fd\u306e\u9032\u884c\u6027\u76ae\u819a\u304c\u3093\u60a3\u8005\u304c\u3001\u6cbb\u7642\u7528\u30ef\u30af\u30c1\u30f3\u306e\u8a55\u4fa1\u3092\u52a0\u901f\u3059\u308bNHS\u30d7\u30ed\u30b0\u30e9\u30e0\u306e\u4e00\u74b0\u3068\u3057\u3066\u3001\u91dd\u4e0d\u8981\u306eDNA\u30ef\u30af\u30c1\u30f3iSCIB1+\u306e\u6cbb\u9a13\u306b\u53c2\u52a0\u3057\u307e\u3057\u305f\u3002<br \/>\n*   2025\u5e743\u6708: Merck\u304c\u3001\u62e1\u5927\u3059\u308b\u6cbb\u7642\u7528\u30ef\u30af\u30c1\u30f3\u30d1\u30a4\u30d7\u30e9\u30a4\u30f3\u3092\u652f\u63f4\u3059\u308b\u305f\u3081\u3001\u5c02\u7528\u306e\u30ef\u30af\u30c1\u30f3\u751f\u7523\u65bd\u8a2d\u3092\u958b\u8a2d\u3057\u3001\u696d\u754c\u5168\u4f53\u306e\u5236\u7d04\u3092\u7de9\u548c\u3059\u308b\u80fd\u529b\u3092\u8ffd\u52a0\u3057\u307e\u3057\u305f\u3002<br \/>\n*   2024\u5e746\u6708: WACKER\u304c\u30c9\u30a4\u30c4\u306e\u30cf\u30ec\u306bmRNA\u30b3\u30f3\u30d4\u30c6\u30f3\u30b9\u30bb\u30f3\u30bf\u30fc\u3092\u958b\u8a2d\u3057\u3001\u5e74\u95932\u5104\u56de\u4ee5\u4e0a\u306e\u751f\u7523\u80fd\u529b\u3092\u53ef\u80fd\u306b\u3059\u308b\u305f\u30811\u5104\u30e6\u30fc\u30ed\u4ee5\u4e0a\u3092\u6295\u8cc7\u3057\u307e\u3057\u305f\u3002<br \/>\n*   2024\u5e742\u6708: Helmholtz Munich\u3068\u305d\u306e\u30d1\u30fc\u30c8\u30ca\u30fc\u304c\u3001\u6162\u6027B\u578b\u809d\u708e\u3092\u6a19\u7684\u3068\u3059\u308b\u6cbb\u7642\u7528\u30ef\u30af\u30c1\u30f3TherVacB\u306e\u7b2cI\u76f8\u8a66\u9a13\u3092\u958b\u59cb\u3057\u3001\u5065\u5eb7\u306a\u30dc\u30e9\u30f3\u30c6\u30a3\u30a2\u306b\u304a\u3051\u308b\u5b89\u5168\u6027\u3068\u514d\u75ab\u539f\u6027\u3092\u8a55\u4fa1\u3057\u307e\u3057\u305f\u3002<\/p>\n<p>\u3053\u306e\u30ec\u30dd\u30fc\u30c8\u306f\u3001\u6cbb\u7642\u7528\u30ef\u30af\u30c1\u30f3\u5e02\u5834\u306b\u95a2\u3059\u308b\u8a73\u7d30\u306a\u5206\u6790\u3092\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002\u6cbb\u7642\u7528\u30ef\u30af\u30c1\u30f3\u306f\u3001\u611f\u67d3\u75c7\u3084\u75be\u60a3\u304c\u767a\u751f\u3057\u305f\u5f8c\u306b\u9069\u7528\u3055\u308c\u3001\u6297\u30a6\u30a4\u30eb\u30b9\u514d\u75ab\u3092\u8a98\u5c0e\u3057\u3001\u75be\u60a3\u306e\u7d4c\u904e\u3092\u5909\u5316\u3055\u305b\u308b\u3053\u3068\u3092\u76ee\u7684\u3068\u3057\u3066\u3044\u307e\u3059\u3002\u3053\u308c\u3089\u306f\u3001\u5c06\u6765\u306e\u75be\u60a3\u4e88\u9632\u306e\u305f\u3081\u306e\u514d\u75ab\u4ed8\u4e0e\u3067\u306f\u306a\u304f\u3001\u60a3\u8005\u81ea\u8eab\u306e\u514d\u75ab\u30b7\u30b9\u30c6\u30e0\u3068\u9023\u643a\u3057\u3066\u611f\u67d3\u75c7\u3068\u95d8\u3044\u3001\u75be\u60a3\u3092\u6cbb\u7642\u3059\u308b\u305f\u3081\u306b\u4f7f\u7528\u3055\u308c\u307e\u3059\u3002<\/p>\n<p>\u672c\u30ec\u30dd\u30fc\u30c8\u3067\u306f\u3001\u88fd\u54c1\uff08\u81ea\u5df1\u514d\u75ab\u75be\u60a3\u30ef\u30af\u30c1\u30f3\u3001\u795e\u7d4c\u75be\u60a3\u30ef\u30af\u30c1\u30f3\u3001\u304c\u3093\u30ef\u30af\u30c1\u30f3\u3001\u611f\u67d3\u75c7\u30ef\u30af\u30c1\u30f3\u3001\u305d\u306e\u4ed6\uff09\u3001\u6280\u8853\uff08\u540c\u7a2e\u30ef\u30af\u30c1\u30f3\u3001\u81ea\u5bb6\u30ef\u30af\u30c1\u30f3\uff09\u3001\u304a\u3088\u3073\u5730\u57df\uff08\u5317\u7c73\u3001\u6b27\u5dde\u3001\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b\u3001\u4e2d\u6771\u30fb\u30a2\u30d5\u30ea\u30ab\u3001\u5357\u7c73\uff09\u5225\u306b\u5e02\u5834\u3092\u30bb\u30b0\u30e1\u30f3\u30c8\u5316\u3057\u3001\u4e3b\u8981\u5730\u57df\u306b\u304a\u3051\u308b17\u30ab\u56fd\u306e\u5e02\u5834\u898f\u6a21\u3068\u30c8\u30ec\u30f3\u30c9\u3092USD\u767e\u4e07\u5358\u4f4d\u3067\u63a8\u5b9a\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u6cbb\u7642\u7528\u30ef\u30af\u30c1\u30f3\u5e02\u5834\u306f\u30012025\u5e74\u306b\u306f304.4\u5104\u7c73\u30c9\u30eb\u306e\u4fa1\u5024\u304c\u3042\u308b\u3068\u8a55\u4fa1\u3055\u308c\u3066\u304a\u308a\u30012030\u5e74\u307e\u3067\u306b\u306f552.1\u5104\u7c73\u30c9\u30eb\u306b\u9054\u3059\u308b\u3068\u4e88\u6e2c\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u5e02\u5834\u306e\u6210\u9577\u3092\u727d\u5f15\u3059\u308b\u4e3b\u306a\u8981\u56e0\u3068\u3057\u3066\u306f\u3001\u6162\u6027\u75be\u60a3\u304a\u3088\u3073\u611f\u67d3\u75c7\u306e\u6709\u75c5\u7387\u306e\u5897\u52a0\u304c\u6319\u3052\u3089\u308c\u307e\u3059\u3002\u307e\u305f\u3001\u30ef\u30af\u30c1\u30f3\u7814\u7a76\u958b\u767a\u306b\u5bfe\u3059\u308b\u653f\u5e9c\u8cc7\u91d1\u306e\u5f37\u5316\u3001\u88fd\u85ac\u30fb\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u4f01\u696d\u306b\u304a\u3051\u308b\u816b\u760d\u30ef\u30af\u30c1\u30f3\u30d1\u30a4\u30d7\u30e9\u30a4\u30f3\u306e\u6025\u5897\u3082\u91cd\u8981\u306a\u63a8\u9032\u529b\u3068\u306a\u3063\u3066\u3044\u307e\u3059\u3002\u753b\u671f\u7684\u306amRNA\u30d9\u30fc\u30b9\u306e\u6cbb\u7642\u7528\u30ef\u30af\u30c1\u30f3\u306e\u627f\u8a8d\u3084\u3001AI\u3092\u6d3b\u7528\u3057\u305f\u30cd\u30aa\u6297\u539f\u767a\u898b\u306b\u3088\u308b\u500b\u5225\u5316\u533b\u7642\u306e\u52a0\u901f\u3082\u5e02\u5834\u62e1\u5927\u306b\u8ca2\u732e\u3057\u3066\u3044\u307e\u3059\u3002\u3055\u3089\u306b\u3001\u30aa\u30f3\u30b5\u30a4\u30c8\u306e\u30e2\u30b8\u30e5\u30e9\u30fc\u578b\u30de\u30a4\u30af\u30ed\u30d5\u30a1\u30af\u30c8\u30ea\u30fc\u88fd\u9020\u30e2\u30c7\u30eb\u306e\u5c0e\u5165\u3082\u52b9\u7387\u5316\u3092\u4fc3\u9032\u3057\u3066\u3044\u307e\u3059\u3002\u4f8b\u3048\u3070\u3001\u7c73\u56fd\u653f\u5e9c\u306e\u300cProject NextGen\u300d\u306e\u3088\u3046\u306a\u30d7\u30ed\u30b0\u30e9\u30e0\u306f\u3001\u6b21\u4e16\u4ee3\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306b50\u5104\u7c73\u30c9\u30eb\u3092\u6295\u3058\u3001\u521d\u671f\u6bb5\u968e\u306e\u30ea\u30b9\u30af\u3092\u4f4e\u6e1b\u3057\u3001\u5546\u696d\u5316\u3092\u52a0\u901f\u3055\u305b\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u4e00\u65b9\u3067\u3001\u5e02\u5834\u306b\u306f\u3044\u304f\u3064\u304b\u306e\u8ab2\u984c\u3082\u5b58\u5728\u3057\u307e\u3059\u3002\u8cc7\u672c\u96c6\u7d04\u7684\u3067\u30ea\u30b9\u30af\u306e\u9ad8\u3044\u81e8\u5e8a\u958b\u767a\u30b5\u30a4\u30af\u30eb\u3001\u8907\u6570\u306e\u7ba1\u8f44\u533a\u57df\u306b\u308f\u305f\u308b\u53b3\u683c\u306a\u898f\u5236\u4e0a\u306e\u30cf\u30fc\u30c9\u30eb\u3001\u305d\u3057\u3066GMP\uff08\u533b\u85ac\u54c1\u88fd\u9020\u7ba1\u7406\u304a\u3088\u3073\u54c1\u8cea\u7ba1\u7406\u57fa\u6e96\uff09\u306b\u6e96\u62e0\u3057\u305f\u30a6\u30a4\u30eb\u30b9\u30d9\u30af\u30bf\u30fc\u3084\u30d7\u30e9\u30b9\u30df\u30c9\u306e\u88fd\u9020\u80fd\u529b\u306e\u4e0d\u8db3\u304c\u6319\u3052\u3089\u308c\u307e\u3059\u3002\u307e\u305f\u3001\u5f8c\u671f\u6bb5\u968e\u306e\u514d\u75ab\u816b\u760d\u5b66\uff08I-O\uff09\u8a66\u9a13\u306e\u5931\u6557\u304c\u6295\u8cc7\u5bb6\u306e\u30bb\u30f3\u30c1\u30e1\u30f3\u30c8\u3092\u51b7\u3048\u8fbc\u307e\u305b\u308b\u8981\u56e0\u3068\u306a\u3063\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u88fd\u54c1\u30bb\u30b0\u30e1\u30f3\u30c8\u5225\u3067\u306f\u3001\u304c\u3093\u30ef\u30af\u30c1\u30f3\u304c2024\u5e74\u306b43.21%\u306e\u5e02\u5834\u30b7\u30a7\u30a2\u3092\u5360\u3081\u3001\u6700\u5927\u306e\u53ce\u76ca\u6e90\u3068\u306a\u3063\u3066\u3044\u307e\u3059\u3002\u3053\u308c\u306f\u3001\u5f37\u529b\u306a\u81e8\u5e8a\u7684\u6709\u52b9\u6027\u3068\u816b\u760d\u5b66\u5206\u91ce\u306b\u304a\u3051\u308b\u9ad8\u3044\u9700\u8981\u306b\u8d77\u56e0\u3057\u3066\u3044\u307e\u3059\u3002\u6280\u8853\u5225\u3067\u306f\u3001\u540c\u7a2e\uff08Allogeneic\uff09\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u304c2024\u5e74\u306e\u53ce\u76ca\u306e65.34%\u3092\u5360\u3081\u3066\u3044\u307e\u3059\u304c\u3001\u81ea\u5bb6\uff08Autologous\uff09\u30d5\u30a9\u30fc\u30de\u30c3\u30c8\u306f\u5e74\u5e73\u5747\u6210\u9577\u7387\uff08CAGR\uff0913.44%\u3068\u3088\u308a\u901f\u3044\u30da\u30fc\u30b9\u3067\u6210\u9577\u3057\u3066\u3044\u307e\u3059\u3002\u5730\u57df\u5225\u3067\u306f\u3001\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b\u5730\u57df\u304c2030\u5e74\u307e\u3067\u306b13.69%\u3068\u3044\u3046\u6700\u3082\u9ad8\u3044CAGR\u3092\u8a18\u9332\u3057\u3001\u88fd\u9020\u4e0a\u306e\u512a\u4f4d\u6027\u3068\u898f\u5236\u306e\u8fd1\u4ee3\u5316\u306b\u3088\u3063\u3066\u6210\u9577\u3092\u727d\u5f15\u3059\u308b\u3068\u898b\u8fbc\u307e\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u30ec\u30dd\u30fc\u30c8\u306b\u306f\u3001Agenus Inc.\u3001GlaxoSmithKline plc\u3001Merck &#038; Co., Inc.\u3001Novartis AG\u3001Pfizer Inc.\u3001AstraZeneca plc\u3001BioNTech SE\u3001Moderna, Inc.\u3001Sanofi SA\u3001Takeda Pharmaceutical Co.\u306a\u3069\u3001\u4e3b\u8981\u4f01\u696d\u306e\u30d7\u30ed\u30d5\u30a1\u30a4\u30eb\u3001\u5e02\u5834\u96c6\u4e2d\u5ea6\u3001\u5e02\u5834\u30b7\u30a7\u30a2\u5206\u6790\u304c\u542b\u307e\u308c\u3066\u3044\u307e\u3059\u3002\u5e02\u5834\u306e\u6a5f\u4f1a\u3068\u5c06\u6765\u306e\u5c55\u671b\u306b\u3064\u3044\u3066\u3082\u3001\u672a\u958b\u62d3\u5206\u91ce\u3084\u6e80\u305f\u3055\u308c\u3066\u3044\u306a\u3044\u30cb\u30fc\u30ba\u306e\u8a55\u4fa1\u3092\u901a\u3058\u3066\u5206\u6790\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/posts\/76523"}],"collection":[{"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/comments?post=76523"}],"version-history":[{"count":1,"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/posts\/76523\/revisions"}],"predecessor-version":[{"id":76526,"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/posts\/76523\/revisions\/76526"}],"wp:attachment":[{"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/media?parent=76523"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/categories?post=76523"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/tags?post=76523"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}